[Form 4] EDGEWELL PERSONAL CARE Co Insider Trading Activity

Rhea-AI Filing Summary

Edgewell Personal Care (EPC) reported insider equity activity by its CFO on a Form 4. On 11/13/2025, 2,754 performance stock equivalents were exercised at $0 and converted into common stock, while 958 shares were withheld at $18.39 to cover tax liabilities. Following these transactions, the CFO directly held 27,536 shares of common stock. In a related derivative transaction, the original performance award was 3,900 shares, of which 2,754 vested and 1,146 were cancelled based on performance criteria. On 11/14/2025, the CFO also received 26,476 restricted stock equivalents, scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WEISSMAN FRANCESCA

(Last) (First) (Middle)

C/O EDGEWELL PERSONAL CARE COMPANY

6 RESEARCH DRIVE

(Street)

SHELTON CT 06484

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EDGEWELL PERSONAL CARE Co [ EPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		M		2,754	A	$0	28,494	D
Common Stock	11/13/2025		F		958(1)	D	$18.39	27,536	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Equivalents 11-11-2022	$0	11/13/2025		M			2,754	11/13/2025	(2)	Common Stock	2,754	$18.39	0	D
Restricted Stock Equivalents 11-14-2025	$0	11/14/2025		A		26,476		11/14/2026	(3)	Common Stock	26,476	$0	26,476	D

Explanation of Responses:

1. Shares withheld as payment of a tax liability on vesting of performance stock equivalents.

2. Performance stock equivalents vested and converted into shares of EPC common stock on 11/13/2025. The original award was 3,900 shares; only 2,754 vested in accordance with the performance criteria. The remaining 1,146 were cancelled.

3. One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events.

	/s/ Francesca Weissman	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did EPC's CFO report on this Form 4?

The CFO of Edgewell Personal Care (EPC) reported the vesting and conversion of 2,754 performance stock equivalents into common stock on 11/13/2025, along with tax share withholding and a new restricted stock equivalent grant.

How many EPC shares did the CFO acquire and what was withheld for taxes?

The CFO acquired 2,754 shares of EPC common stock at an exercise price of $0, and 958 shares were disposed of at $18.39 per share to satisfy tax liabilities on the vesting.

What is the CFO's EPC common stock ownership after these transactions?

After the reported transactions, the CFO directly owned 27,536 shares of Edgewell Personal Care common stock.

What happened to the original 3,900 performance stock equivalents award at EPC?

The original performance award was 3,900 performance stock equivalents. On 11/13/2025, 2,754 vested and converted into EPC common stock, while the remaining 1,146 were cancelled in line with the performance criteria.

What new restricted stock equivalents did EPC grant to the CFO?

On 11/14/2025, the CFO received 26,476 restricted stock equivalents. One-third will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028, subject to continued employment or specified events.

Are the new EPC restricted stock equivalents subject to any conditions?

Yes. The 26,476 restricted stock equivalents will vest in three equal annual installments if the CFO remains employed on 11/14/2026, 11/14/2027 and 11/14/2028, or may vest earlier upon death, disability, change in control or certain termination events.